SMS Pharmaceuticals Ltd. Financials: Quarterly Results
Revenue
214.2
Cr.
PAT
23.19
Cr.
EBITDA
37.38
Cr.
SMS Pharmaceuticals Ltd. Q3FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 210.45 | 242.43 | 196.05 | 248.20 | 173.35 |
| Total Income From Operations (Cr.) | 210.45 | 242.43 | 196.05 | 248.20 | 173.35 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 37.38 | 39.78 | 30.21 | 33.59 | 26.64 |
| P/L Before Exceptional Items & Tax (Cr.) | 31.16 | 34.04 | 24.37 | 28.52 | 22.44 |
| P/L After Tax from Ordinary Activities (Cr.) | 23.19 | 25.13 | 18.71 | 20.08 | 17.08 |
| Net Profit/Loss For the Period (Cr.) | 23.19 | 25.13 | 18.71 | 20.08 | 17.08 |
| Basic EPS | 2.59 | 2.84 | 2.31 | 2.40 | 2.15 |
FAQs
SMS Pharmaceuticals Ltd. announced its quarterly results for Q3 FY2026 on February 9, 2026.
In Q3 FY2026, SMS Pharmaceuticals Ltd. are as follows:
Revenue: ₹214.2 crore
Net Profit: ₹23.19 crore.
For Q3 FY2026, SMS Pharmaceuticals Ltd. posted ₹214.2 crore in revenue and ₹23.19 crore in net profit.
Past quarterly results for SMS Pharmaceuticals Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.